
AI Doctor Blog

Regulatory Landscape of AI in Healthcare II
- Ronald M. Razmi, MD
- February 22, 2022
The debate over how the FDA should regulate the emerging solutions that use AI for healthcare applications is one that is attracting opposite but truly equally valid points of view. Baku Patel, former head...

Regulatory Landscape of AI in Healthcare I
- Ronald M. Razmi, MD
- February 15, 2022
Before any new diagnostic or therapeutic, or technology can be used in the practice of healthcare, it has to be deemed safe and effective by certain regulatory bodies. US, EU, Japan, and others have robust...

Mitigating Risk of AI Algorithm Deployment
- Ronald M. Razmi, MD
- February 8, 2022
Evidence-based AI is not exclusive to showing that AI algorithms will improve patient outcomes, improve clinical workflows, or lower the cost of care. Currently there is a great deal of variability in risk-mitigating AI development...

What Evidence Will Cut it for AI Solutions in Healthcare?
- Ronald M. Razmi, MD
- February 1, 2022
My discussions with many of the experts in AI in Healthcare has highlighted the fact that well-designed, large-scale, multi-center trials have not been done so far. These types of trials would establish the efficacy and...

Myriad of Issues Facing Adoption of AI in Healthcare
- Ronald M. Razmi, MD
- January 25, 2022
According to a survey of over 12,000 participants conducted by the consultancy PwC, lack of trust and a need for the human element were the biggest hurdles to using AI in healthcare. Another survey by KPMG in...